Showing results (161-170 of 297) with videos related to

Sort By:
Pageof 30
Acta Haematologica|June 19, 2022
A Phase II Study of Azacitidine, Venetoclax, and Trametinib in Relapsed or Refractory Acute Myeloid Leukemia Harboring RAS Pathway-Activating MutationsSai Prasad Desikan, Farhad Ravandi, Naveen Pemmaraju, et al.
American Journal of Hematology|August 5, 2021
Development of TP53 mutations over the course of therapy for acute myeloid leukemiaYasmin Alwash, Joseph D Khoury, Mehrnoosh Tashakori, et al.
Human Pathology|August 8, 2018
Chronic lymphocytic leukemia with proliferation centers in bone marrow is associated with younger age at initial presentation, complex karyotype, and TP53 disruptionSofia Garces, Joseph D Khoury, Rashmi Kanagal-Shamanna, et al.
American Journal of Hematology|May 15, 2023
Ultrasensitive NGS MRD assessment in Ph+ ALL: Prognostic impact and correlation with RT-PCR for BCR::ABL1Nicholas J Short, Elias Jabbour, Walid Macaron, et al.
Bone Marrow Transplantation|January 7, 2022
Acquired WT1 mutations contribute to relapse of NPM1-mutated acute myeloid leukemia following allogeneic hematopoietic stem cell transplantSiba El Hussein, Courtney D DiNardo, Koichi Takahashi, et al.
Cancer|April 7, 2025
Cladribine, idarubicin, and cytarabine (CLIA) for patients with relapsed and/or refractory acute myeloid leukemia: A single-center, single-arm, phase 2 trialHannah Goulart, Hagop Kantarjian, Gautam Borthakur, et al.
Cancer|July 17, 2019
Sorafenib plus intensive chemotherapy improves survival in patients with newly diagnosed, FLT3-internal tandem duplication mutation-positive acute myeloid leukemiaKoji Sasaki, Hagop M Kantarjian, Tapan Kadia, et al.
Blood|April 7, 2022
TP53 copy number and protein expression inform mutation status across risk categories in acute myeloid leukemiaMehrnoosh Tashakori, Tapan Kadia, Sanam Loghavi, et al.
Blood Cancer Journal|January 26, 2022
Efficacy and safety of enasidenib and azacitidine combination in patients with IDH2 mutated acute myeloid leukemia and not eligible for intensive chemotherapySangeetha Venugopal, Koichi Takahashi, Naval Daver, et al.
Leukemia Research|April 17, 2022
Landscape of NOTCH1 mutations and co-occurring biomarker alterations in chronic lymphocytic leukemiaFatima Zahra Jelloul, Richard Yang, Sofia Garces, et al.
Pageof 30